A novel nanoparticle containing MOG peptide with BTLA induces T cell tolerance and prevents multiple sclerosis
- PMID: 24084097
- DOI: 10.1016/j.molimm.2013.08.006
A novel nanoparticle containing MOG peptide with BTLA induces T cell tolerance and prevents multiple sclerosis
Abstract
Accumulative evidence demonstrates that multiple sclerosis (MS) is caused by activation of myelin Ag-reactive CD4+ T cells. Therefore, the CD4+ T cells specific for myelin Ag may be the important therapeutical target of MS. The novel coinhibitory receptor B and T lymphocyte attenuator (BTLA) may have a regulatory role in maintaining peripheral tolerance, however, its role in MS is still unknown. In this study, a novel nanoparticle containing MOG peptide with BTLA was designed and transduced into dendritic cells (DCs), and MOG peptide-induced EAE mice were administrated with the genetically modified DCs in vivo. The results demonstrated that modified DCs significantly enhanced the proportion of Foxp3+ CD4+ regulatory T cells, increased IL-10 and TGF-β cytokine secretion, while decreased IL-2 and IFN-γ cytokine secretion. Furthermore, modified DCs supressed the CD4+ T cell response to MOG, cell infiltration into spinal cord, and the severity of EAE. In contrast, immune response to irrelevant exogenous Ag was not impaired by treatment with modified DCs. These findings suggested that DCs transduced with nanoparticle could induce specific CD4+ T-cells tolerance, which provided a promising therapeutic means to negatively manipulate immune response for autoimmune diseases without inhibition of the immune response to irrelevant Ag.
Keywords: BTLA; MOG peptide; Multiple sclerosis; Nanoparticle; T cell tolerance.
Copyright © 2013 Elsevier Ltd. All rights reserved.
Similar articles
-
Immune tolerance induced by intravenous transfer of immature dendritic cells via up-regulating numbers of suppressive IL-10(+) IFN-γ(+)-producing CD4(+) T cells.Immunol Res. 2013 May;56(1):1-8. doi: 10.1007/s12026-012-8382-7. Immunol Res. 2013. PMID: 23292714 Free PMC article.
-
Selective depletion of CD11c+ CD11b+ dendritic cells partially abrogates tolerogenic effects of intravenous MOG in murine EAE.Eur J Immunol. 2016 Oct;46(10):2454-2466. doi: 10.1002/eji.201546274. Eur J Immunol. 2016. PMID: 27338697 Free PMC article.
-
Early life exposure to lipopolysaccharide suppresses experimental autoimmune encephalomyelitis by promoting tolerogenic dendritic cells and regulatory T cells.J Immunol. 2009 Jul 1;183(1):298-309. doi: 10.4049/jimmunol.0803576. J Immunol. 2009. PMID: 19542441
-
Immunopathogenesis of multiple sclerosis: concepts and controversies.Acta Neurol Scand Suppl. 2007;187:39-45. doi: 10.1111/j.1600-0404.2007.00845.x. Acta Neurol Scand Suppl. 2007. PMID: 17419827 Review.
-
Control of experimental autoimmune encephalomyelitis by CD4+ suppressor T cells: peripheral versus in situ immunoregulation.J Neuroimmunol. 2007 Nov;191(1-2):61-9. doi: 10.1016/j.jneuroim.2007.09.010. Epub 2007 Sep 27. J Neuroimmunol. 2007. PMID: 17900707 Free PMC article. Review.
Cited by
-
Designing drug-free biodegradable nanoparticles to modulate inflammatory monocytes and neutrophils for ameliorating inflammation.J Control Release. 2019 Apr 28;300:185-196. doi: 10.1016/j.jconrel.2019.02.025. Epub 2019 Feb 27. J Control Release. 2019. PMID: 30822435 Free PMC article.
-
Nano-based approaches for the treatment of neuro-immunological disorders: a special emphasis on multiple sclerosis.Discov Nano. 2024 Oct 28;19(1):171. doi: 10.1186/s11671-024-04135-0. Discov Nano. 2024. PMID: 39466516 Free PMC article. Review.
-
Administration methods and dosage of poly(lactic acid)-glycol intervention to myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalitis mice.BMC Neurosci. 2024 Mar 11;25(1):16. doi: 10.1186/s12868-024-00859-y. BMC Neurosci. 2024. PMID: 38468222 Free PMC article.
-
Infusion of Sulfosuccinimidyl-4-[N-maleimidomethyl]cyclohexane-1-carboxylate-Conjugated MOG35-55-Coupled Spleen Cells Effectively Prevents and Reverses Experimental Autoimmune Encephalomyelitis in Mice.J Immunol Res. 2015;2015:129682. doi: 10.1155/2015/129682. Epub 2015 Jul 14. J Immunol Res. 2015. PMID: 26258148 Free PMC article.
-
Design of biodegradable nanoparticles to modulate phenotypes of antigen-presenting cells for antigen-specific treatment of autoimmune disease.Biomaterials. 2019 Nov;222:119432. doi: 10.1016/j.biomaterials.2019.119432. Epub 2019 Aug 17. Biomaterials. 2019. PMID: 31480002 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials